Raised XXXX in erythrocytes from @entity320 -bearing @entity19 and @entity1 with solid @entity5 .

@entity1 @entity19 @entity5 @entity8037 @entity7224 @entity4663 @entity4664 @entity320 @entity11667
The levels of @entity4663 ( @entity7224 , @entity11667 and @entity8037 ) in erythrocytes and plasma were studied using Cloudman S-91 @entity320 grown in the lungs of DBA/2 @entity19 . @entity4664 levels and the numbers of @entity5 -cell colonies in the lungs were determined at weekly intervals. @entity7224 levels in both erythrocytes and plasma significantly increased 1 week after @entity5 inoculation. Three weeks after inoculation, however, @entity7224 levels in the erythrocytes showed a greater increase than those in plasma. @entity11667 and @entity8037 levels were initially high at 2 weeks in plasma and at 4 weeks in erythrocytes. However, by 6 weeks the @entity11667 levels showed a greater increase in erythrocytes than in plasma. These data suggest that erythrocytes may absorb and store @entity4663 released into the circulation.This finding was subsequently applied to @entity1 studies. Fifty-two untreated @entity1 with solid @entity5 were examined in the preoperative period. All erythrocyte @entity4664 levels from @entity1 were significantly higher than those from control subjects. Plasma @entity11667 levels in @entity1 were significantly higher than those in controls, whereas plasma @entity7224 and @entity8037 levels showed no significant increase. The frequency of raised levels of @entity7224 , @entity11667 and @entity8037 in erythrocytes was significantly greater than in plasma. These results suggest that @entity4664 levels in erythrocytes may provide useful information for the detection of @entity5 .
